Literature DB >> 31104013

E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.

Kirti Gondkar1,2, Krishna Patel1,2, Shobha Krishnappa3, Akkamahadevi Patil4, Bipin Nair2, Gopinath Meenakshi Sundaram5, Tan Tuan Zea6, Prashant Kumar1,7.   

Abstract

BACKGROUND: Transcription factors are commonly deregulated in various cancers. Here, we evaluated role of ELF3 in pathogenesis of bladder carcinoma (BCa).
MATERIALS AND METHODS: We confirmed ELF3 expression pattern in BCa cell lines using western blot; and in different grades of tumors using Immunohistochemistry. Cell invasion assay was employed to demonstrate potential role of ELF3 in EMT. RESULTS AND
CONCLUSION: ELF3 showed selective expression in low-grade cell lines and tumor tissues. Overexpression of ELF3 in mesenchymal cell line UMUC3 resulted in reduced invasion and decreased expression of mesenchymal markers. We observed association of low ELF3 expression with increased risk and overall poor survival using publicly available data. ELF3-modulated reversal of EMT might be a useful strategy in the treatment of bladder cancer.

Entities:  

Keywords:  EMT; ETS transcription factor; bladder cancer

Mesh:

Substances:

Year:  2019        PMID: 31104013     DOI: 10.3233/CBM-190013

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  6 in total

1.  Identification of the gene expression changes and gene regulatory aspects in ELF3 mutant bladder cancer.

Authors:  Perihan Yagmur Guneri-Sozeri; Serap Erkek-Ozhan
Journal:  Mol Biol Rep       Date:  2022-02-24       Impact factor: 2.316

2.  Context specificity of the EMT transcriptional response.

Authors:  David P Cook; Barbara C Vanderhyden
Journal:  Nat Commun       Date:  2020-05-01       Impact factor: 14.919

3.  Dickkopf Homolog 3 (DKK3) Acts as a Potential Tumor Suppressor in Gallbladder Cancer.

Authors:  Kirti Gondkar; Krishna Patel; Geeta V Patil Okaly; Bipin Nair; Akhilesh Pandey; Harsha Gowda; Prashant Kumar
Journal:  Front Oncol       Date:  2019-10-29       Impact factor: 6.244

4.  Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer.

Authors:  Kirti Gondkar; Gajanan Sathe; Neha Joshi; Bipin Nair; Akhilesh Pandey; Prashant Kumar
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

5.  Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R.

Authors:  Seung Hee Seo; Soo-Yeon Hwang; Seohui Hwang; Sunjung Han; Hyojin Park; Yun-Sil Lee; Seung Bae Rho; Youngjoo Kwon
Journal:  EMBO Rep       Date:  2022-06-13       Impact factor: 9.071

6.  Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy.

Authors:  Ryul Kim; Jung Yong Hong; Jeeyun Lee; Ghee Young Kwon; Byong Chang Jeong; Se Hoon Park
Journal:  Cancer Res Treat       Date:  2021-11-17       Impact factor: 5.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.